Myeloproliferative neoplasm with eosinophilia and platelet-derived growth factor receptor-alpha gene and Fip1-like 1 gene mutation (FIP1L1-PDGFRA; F/P) is a low-burden disease with dramatic response to imatinib therapy. Here, FIP1L1 is linked to Increased total eosinophil count.